Company Filing History:
Years Active: 2014-2019
Title: Innovations of Katrin Hoffman
Introduction
Katrin Hoffman is an accomplished inventor based in Aubin Grove, Australia. She has made significant contributions to the field of biotechnology, particularly in the development of cell-penetrating peptides. With a total of 3 patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
One of her latest patents is a method for determining, identifying, or isolating cell-penetrating peptides (CPPs). This invention focuses on CPPs that exhibit cell-type selectivity and the ability to cross the Blood Brain Barrier in animal subjects. The patent outlines the provision of CPPs and their analogs, including those detailed in SEQ ID NOs: 1-27 of the Sequence Listing. Additionally, it describes compositions that incorporate these CPPs, including conjugates linked to cargo molecules. The methods proposed aim to transport cargo molecules across cell membranes to specific cellular locations, facilitating the treatment, prevention, and diagnosis of diseases that can be addressed by the attached cargo molecules. Furthermore, the invention includes tailored peptide libraries for identifying or isolating CPPs.
Career Highlights
Katrin Hoffman is currently associated with Phylogica Limited, where she continues to innovate in her field. Her work has garnered attention for its potential applications in therapeutic contexts, particularly in targeting diseases that require precise delivery mechanisms.
Collaborations
Katrin collaborates with notable colleagues, including Paul Michael Watt and Richard Hopkins, who contribute to her research endeavors and the advancement of her inventions.
Conclusion
Katrin Hoffman's innovative work in the realm of cell-penetrating peptides showcases her dedication to advancing biotechnology. Her patents reflect a commitment to improving medical treatments and enhancing the delivery of therapeutic agents.